Net Cash Provided by (Used in) Operating Activities |
-241K |
USD |
-223% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
158K |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-20K |
USD |
0% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
26.1M |
shares |
+135% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-103K |
USD |
-8.97% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
734K |
USD |
+296% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
734K |
USD |
+272% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
313K |
USD |
+58.7% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
16.3M |
USD |
+357% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Interest Expense |
1.62K |
USD |
|
Q3 2022 |
Q3 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |